These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 24323636)

  • 21. Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.
    de Wilde AH; Jochmans D; Posthuma CC; Zevenhoven-Dobbe JC; van Nieuwkoop S; Bestebroer TM; van den Hoogen BG; Neyts J; Snijder EJ
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4875-84. PubMed ID: 24841269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus.
    Scheuplein VA; Seifried J; Malczyk AH; Miller L; Höcker L; Vergara-Alert J; Dolnik O; Zielecki F; Becker B; Spreitzer I; König R; Becker S; Waibler Z; Mühlebach MD
    J Virol; 2015 Apr; 89(7):3859-69. PubMed ID: 25609809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.
    Rathnayake AD; Zheng J; Kim Y; Perera KD; Mackin S; Meyerholz DK; Kashipathy MM; Battaile KP; Lovell S; Perlman S; Groutas WC; Chang KO
    Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32747425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin.
    Falzarano D; de Wit E; Martellaro C; Callison J; Munster VJ; Feldmann H
    Sci Rep; 2013; 3():1686. PubMed ID: 23594967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis.
    Zhou J; Chu H; Li C; Wong BH; Cheng ZS; Poon VK; Sun T; Lau CC; Wong KK; Chan JY; Chan JF; To KK; Chan KH; Zheng BJ; Yuen KY
    J Infect Dis; 2014 May; 209(9):1331-42. PubMed ID: 24065148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of SARS-CoV-2 by type I and type III interferons.
    Felgenhauer U; Schoen A; Gad HH; Hartmann R; Schaubmar AR; Failing K; Drosten C; Weber F
    J Biol Chem; 2020 Oct; 295(41):13958-13964. PubMed ID: 32587093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclophilin inhibitors restrict Middle East respiratory syndrome coronavirus
    Sauerhering L; Kupke A; Meier L; Dietzel E; Hoppe J; Gruber AD; Gattenloehner S; Witte B; Fink L; Hofmann N; Zimmermann T; Goesmann A; Nist A; Stiewe T; Becker S; Herold S; Peteranderl C
    Eur Respir J; 2020 Nov; 56(5):. PubMed ID: 32616594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets.
    Yang Y; Ye F; Zhu N; Wang W; Deng Y; Zhao Z; Tan W
    Sci Rep; 2015 Dec; 5():17554. PubMed ID: 26631542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
    Malczyk AH; Kupke A; Prüfer S; Scheuplein VA; Hutzler S; Kreuz D; Beissert T; Bauer S; Hubich-Rau S; Tondera C; Eldin HS; Schmidt J; Vergara-Alert J; Süzer Y; Seifried J; Hanschmann KM; Kalinke U; Herold S; Sahin U; Cichutek K; Waibler Z; Eickmann M; Becker S; Mühlebach MD
    J Virol; 2015 Nov; 89(22):11654-67. PubMed ID: 26355094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment.
    Lau SKP; Lau CCY; Chan KH; Li CPY; Chen H; Jin DY; Chan JFW; Woo PCY; Yuen KY
    J Gen Virol; 2013 Dec; 94(Pt 12):2679-2690. PubMed ID: 24077366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ca
    Straus MR; Tang T; Lai AL; Flegel A; Bidon M; Freed JH; Daniel S; Whittaker GR
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).
    Sainz B; Mossel EC; Peters CJ; Garry RF
    Virology; 2004 Nov; 329(1):11-7. PubMed ID: 15476870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inactivation of Middle East respiratory syndrome-coronavirus in human plasma using amotosalen and ultraviolet A light.
    Hindawi SI; Hashem AM; Damanhouri GA; El-Kafrawy SA; Tolah AM; Hassan AM; Azhar EI
    Transfusion; 2018 Jan; 58(1):52-59. PubMed ID: 29239484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute Respiratory Infection in Human Dipeptidyl Peptidase 4-Transgenic Mice Infected with Middle East Respiratory Syndrome Coronavirus.
    Iwata-Yoshikawa N; Okamura T; Shimizu Y; Kotani O; Sato H; Sekimukai H; Fukushi S; Suzuki T; Sato Y; Takeda M; Tashiro M; Hasegawa H; Nagata N
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type I and III IFNs produced by the nasal epithelia and dimmed inflammation are features of alpacas resolving MERS-CoV infection.
    Te N; Rodon J; Ballester M; Pérez M; Pailler-García L; Segalés J; Vergara-Alert J; Bensaid A
    PLoS Pathog; 2021 May; 17(5):e1009229. PubMed ID: 34029358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MERS-CoV papain-like protease has deISGylating and deubiquitinating activities.
    Mielech AM; Kilianski A; Baez-Santos YM; Mesecar AD; Baker SC
    Virology; 2014 Feb; 450-451():64-70. PubMed ID: 24503068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Middle Eastern Respiratory Syndrome Corona Virus (MERS CoV): case reports from a tertiary care hospital in Saudi Arabia.
    Khalid M; Khan B; Al Rabiah F; Alismaili R; Saleemi S; Rehan-Khaliq AM; Weheba I; Al Abdely H; Halim M; Nadri QJ; Al Dalaan AM; Zeitouni M; Butt T; Al Mutairy E
    Ann Saudi Med; 2014; 34(5):396-400. PubMed ID: 25827696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection of viral variants during persistent infection of insectivorous bat cells with Middle East respiratory syndrome coronavirus.
    Banerjee A; Subudhi S; Rapin N; Lew J; Jain R; Falzarano D; Misra V
    Sci Rep; 2020 Apr; 10(1):7257. PubMed ID: 32350357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type I IFNs: A Blessing in Disguise or Partner in Crime in MERS-CoV-, SARS-CoV-, and SARS-CoV-2-Induced Pathology and Potential Use of Type I IFNs in Synergism with IFN-
    Anjum FR; Anam S; Abbas G; Mahmood MS; Rahman SU; Goraya MU; Abdullah RM; Luqman M; Ali A; Akram MK; Chaudhry TH
    Viral Immunol; 2021 Jun; 34(5):321-329. PubMed ID: 33181057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of C-Type Lectin Receptor and (RIG)-I-Like Receptors Contributes to Proinflammatory Response in Middle East Respiratory Syndrome Coronavirus-Infected Macrophages.
    Zhao X; Chu H; Wong BH; Chiu MC; Wang D; Li C; Liu X; Yang D; Poon VK; Cai J; Chan JF; To KK; Zhou J; Yuen KY
    J Infect Dis; 2020 Feb; 221(4):647-659. PubMed ID: 31562757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.